It’s a hat trick for Pegasus!
October 16, 2014 |
Pegasus scoops the much-coveted “Consultancy of the Year” prize at the PR Week Awards 2014
Pegasus, the UK’s leading independent health communications consultancy, picked up the prestigious “Consultancy of the Year” award at Tuesday night’s PR Week Awards 2014.
Pegasus was also successful in the “Mid-Sized Consultancy of the Year” category (for agencies with UK turnover between £2m and £10m), and completed its hat trick winning the “Healthcare: Ethical & OTC Consumer” award for its work on Bayer Animal Health’s Slimewatch campaign.
This win marks Pegasus’s evolution from a traditional PR agency to an integrated comms consultancy that offers a multiservice approach to its clients, including social, digital and creative services.
With campaigns that span local, national and international markets and the creation of a network of global independent affiliate agencies across five continents, it’s no surprise that Pegasus represents a raft of well known companies and brands such as GSK, Pfizer, Bayer, Holland & Barrett, Bio-Oil and Danone to name a few. These awards are further confirmation that the consultancy continues to go from strength to strength, creating outstanding integrated campaigns that really bring healthcare into the mainstream. This is the third consultancy award win for the agency this year.
It has seen five years of double-digit growth, with last year’s fee income of £6m helping it climb ten places in this year’s PR Week Top 150 PR Consultancies report to number 38.
Fishburn CEO, Ali Gee said: “Pegasus has everything; it’s clear who they are, what they do and what makes them special.
Their purpose – inspiring health decisions – defines everything they do, and we were particularly impressed by the way they have reached beyond the healthcare sector.” 
Lisa Bradley, managing director at Pegasus, commented: “We’re absolutely delighted to have won, not just one, but three awards at the PR Week Awards this year. I’ve always looked at the winners of the “Consultancy of the Year” award with great admiration and am so proud that we are now that agency.”
ENDS
For more information please contact Maria Boiling or Amy Simmons at Pegasus on 01273 712000 or mboiling@thisispegasus.co.uk / asimmons@thisispegasus.co.uk
Notes to editors
Located in Brighton with a 75-strong team of communications experts, Pegasus specialises in helping the public and private sector communicate healthy messages through integrated communications programmes. Focusing on an overall mission to ‘Inspire Healthy Decisions’ and driven by a health first, sector second approach, Pegasus has a demonstrative track record of creating and implementing campaigns that inspire change.
The Pegasus approach to planning starts by investing time understanding the varied nature of decisions in every area of people’s day to day lives, from the general public through to the healthcare professionals that treat and the policy makers that shape the environment in which they work. The consultancy’s fully integrated approach blends unrivalled health contacts across the international, national, consumer, regional and specialist press, with in-house corporate, creative, social and digital services.
Pegasus’s clients currently include GSK, Pfizer, Boehringer Ingelheim, Bayer, Thornton & Ross, Holland & Barrett, Sanofi, Bio-Oil, Danone, Homedics, Novo Nordisk and Pierre Fabre. For more information please visit www.thisispegasus.co.uk.
This content was provided by Inizio
Company Details
Latest Content from Inizio
Webcast: AI in MRX: Harnessing the power of AI + people
Artificial intelligence (AI) in market research has surged in recent years, with a flow of innovative tools and techniques which have the potential to revolutionize the landscape. But to unlock...
Navigating challenges of MedTech research with rare-disease patients
Authored by: Tom Donnelly, MedTech Director and Amanda Pirraglia, Associate Director. Published in Quirk's Magazine.
Product launch: What market research when?
Get the insights you need, when you need them, for your product launch planning
Therapy Watch launches new tracker covering Alzheimer’s Disease
The new Therapy Watch Alzheimer’s Disease tracker has recently launched in Germany, Japan and the US, with planned expansion into the remaining key European markets throughout 2024.
Therapy Watch launches new tracker covering pulmonary arterial hypertension (PAH)
Therapy Watch Pulmonary Arterial Hypertension (PAH) is launching in the US market, with expansion into other geographies including Europe in 2024.
Healthcare in the age of AI: How will artificial intelligence impact future decision-making?
Authored by: Constanza Salas, Jhon Galindo and Rachel Howard
Therapy Watch launches new tracker covering Postpartum Depression
The new Therapy Watch Postpartum depression (PPD) study is the first tracker in the series to cover Psychiatry
Value-based pricing reform: Strengthening the ‘front door’ to the Colombian pharmaceutical market
Authored by: Marc Garcia and Tania Rodrigues
Infographic: Rare Diseases in China
How rare are rare diseases in China? Download this infographic to find out more and how we can offer guidance for pharma companies to consider.
New syndicated COPD report now available
Living with COPD 2023